Topiramate Augmentation in Bulimia Nervosa Partial Responders
Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to generate pilot data exploring the addition of an augmentation
(additional) medication to patients suffering from bulimia nervosa who have responded but not
had complete symptom resolution with a course of standard medication treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Neuropsychiatric Research Institute, Fargo, North Dakota